knowledge -WSS

knowledge

author：Wikipedia 2025-09-27 21:55:45 - browse：87

Several amyloid plaques forming between neurons in a brain — Adobe

Expert advisers to the Food and Drug Administration on Friday voted unanimously in favor of expanding the approval of Leqembi, an Alzheimer’s disease treatment from Eisai and Biogen, further clearing the way for what could be the first widely available medicine that delays the disease’s progress.

The group voted 6-0 that an 1,800-patient study of Leqembi confirmed its benefits for patients in the early stages of Alzheimer’s, recommending the FDA widen the drug’s limited approval. The agency, which is not required to follow the suggestions of its advisers, is expected to make a final decision on Leqembi by July 6.

“I thought the clinical results were robust,” said Merit Cudkowicz, a neurologist from Massachusetts General Hospital and one of the experts invited to review Leqembi.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： New case study details death in closely watched Alzhiemer's trial

knowledge

WSS

Leon Gautier, last member of French D

Van's Gluten Free Original Waffles recalled for possible wheat allergen

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

PhRMA sues HHS over Medicare drug price negotiation

3 killed, 8 injured in late

Make 'food is medicine' a key part of White House nutrition meeting

focus

knowledge

entertainment

George Santos makes 1st court appearance after pleading not guilty to 13 counts

US recommends Americans reconsider traveling to China due to arbitrary law enforcement, exit bans

As demand for Covid shots wanes, Moderna seeks its next success

4th of July breaks record for highest global temperature ever measured

Heart attack and stroke risk calculators need revising

Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

Trump demands the U.S. pay no more for drugs than other countries … again

Doctor appointment wait times are getting worse

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Brain 'hot spot' may explain why African Americans feel greater pain

focus

Why is France rioting? What to know about the fatal police shooting of Nahel M

Connecting traumatic brain injury and domestic violence

Can food be medicine? And other questions about a new push

Trump pressured former Arizona governor to overturn 2020 election results: Sources

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

Pfizer's Covid pill remains 89% effective in final analysis, company says

knowledge

hotspot

knowledge

focus